NBIX- Neurocrine Biosciences, Inc.

Name: Neurocrine Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Gano Kyle	140.4K	$23.32M	-
Other	Benevich Eric	52.8K	$8.76M	-
Other	Lippoldt Darin	46.8K	$7.76M	-
Other	Cooke Julie	39.6K	$6.58M	-36,937
Other	Onyia Jude	36.8K	$6.12M	-22,000

Activity

Buys and sells only

Transactions

10 filings · page 29

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Feb 7, 2020	Lippoldt Darin60	Chief Legal Officer	Sell	1,522	$103.32	$157,247.10	-5.9%
Feb 7, 2020	Grigoriadis Dimitri E.	Chief Research Officer	Sell	1,218	$103.31	$125,832.55	-1.1%
Feb 7, 2020	Gorman Kevin Charles55	Chief Executive Officer	Sell	3,248	$103.35	$335,696.07	-0.7%
Feb 7, 2020	Gano Kyle54	Chief Business Development Off	Sell	1,623	$103.33	$167,710.27	-1.7%
Feb 7, 2020	Cooke Julie59	Chief Human Resources Officer	Sell	913	$103.26	$94,276.20	-16.4%
Feb 7, 2020	Bozigian Haig P.	Chief Development Officer	Sell	1,623	$103.33	$167,701.67	-1.1%
Feb 7, 2020	Benevich Eric62	Chief Commercial Officer	Sell	2,030	$103.32	$209,747.31	-9.2%
Feb 7, 2020	Abernethy Matt57	Chief Financial Officer	Sell	2,030	$103.35	$209,806.59	-26.3%
Feb 6, 2020	Gano Kyle54	Chief Business Development Off	Sell	4,690	$102.70	$481,674.98	-1.3%
Feb 6, 2020	Grigoriadis Dimitri E.	Chief Research Officer	Sell	2,421	$102.58	$248,350.51	-0.7%

← PrevPage 29Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC